Repare Therapeutics Inc.

NasdaqGS:RPTX Stok Raporu

Piyasa değeri: US$147.3m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Repare Therapeutics Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Repare Therapeutics şirketinin toplam hissedar öz sermayesi $203.7M ve toplam borcu $0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $235.3M ve $31.7M dir.

Anahtar bilgiler

0%

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranın/a
NakitUS$208.12m
EşitlikUS$203.68m
Toplam yükümlülüklerUS$31.67m
Toplam varlıklarUS$235.34m

Son finansal sağlık güncellemeleri

Recent updates

Repare: Q4 2024 Is A Major Inflection Point With Lunresertib, Camonsertib Data

Aug 30

Will Repare Therapeutics (NASDAQ:RPTX) Spend Its Cash Wisely?

Jul 12
Will Repare Therapeutics (NASDAQ:RPTX) Spend Its Cash Wisely?

Repare Therapeutics Inc.'s (NASDAQ:RPTX) 34% Dip In Price Shows Sentiment Is Matching Revenues

May 01
Repare Therapeutics Inc.'s (NASDAQ:RPTX) 34% Dip In Price Shows Sentiment Is Matching Revenues

Benign Growth For Repare Therapeutics Inc. (NASDAQ:RPTX) Underpins Stock's 30% Plummet

Mar 12
Benign Growth For Repare Therapeutics Inc. (NASDAQ:RPTX) Underpins Stock's 30% Plummet

We Think Repare Therapeutics (NASDAQ:RPTX) Needs To Drive Business Growth Carefully

Feb 15
We Think Repare Therapeutics (NASDAQ:RPTX) Needs To Drive Business Growth Carefully

Repare Therapeutics Inc. (NASDAQ:RPTX) Shares Fly 30% But Investors Aren't Buying For Growth

Dec 20
Repare Therapeutics Inc. (NASDAQ:RPTX) Shares Fly 30% But Investors Aren't Buying For Growth

Here's Why We're Not At All Concerned With Repare Therapeutics' (NASDAQ:RPTX) Cash Burn Situation

Oct 24
Here's Why We're Not At All Concerned With Repare Therapeutics' (NASDAQ:RPTX) Cash Burn Situation

New Forecasts: Here's What Analysts Think The Future Holds For Repare Therapeutics Inc. (NASDAQ:RPTX)

Aug 14
New Forecasts: Here's What Analysts Think The Future Holds For Repare Therapeutics Inc. (NASDAQ:RPTX)

Analysts Are Betting On Repare Therapeutics Inc. (NASDAQ:RPTX) With A Big Upgrade This Week

May 14
Analysts Are Betting On Repare Therapeutics Inc. (NASDAQ:RPTX) With A Big Upgrade This Week

Analysts Are Upgrading Repare Therapeutics Inc. (NASDAQ:RPTX) After Its Latest Results

May 12
Analysts Are Upgrading Repare Therapeutics Inc. (NASDAQ:RPTX) After Its Latest Results

Repare Therapeutics Inc. (NASDAQ:RPTX) Looks Inexpensive But Perhaps Not Attractive Enough

May 08
Repare Therapeutics Inc. (NASDAQ:RPTX) Looks Inexpensive But Perhaps Not Attractive Enough

Growth Investors: Industry Analysts Just Upgraded Their Repare Therapeutics Inc. (NASDAQ:RPTX) Revenue Forecasts By 31%

Mar 03
Growth Investors: Industry Analysts Just Upgraded Their Repare Therapeutics Inc. (NASDAQ:RPTX) Revenue Forecasts By 31%

Companies Like Repare Therapeutics (NASDAQ:RPTX) Are In A Position To Invest In Growth

Oct 27
Companies Like Repare Therapeutics (NASDAQ:RPTX) Are In A Position To Invest In Growth

Repare Therapeutics: Budding Synthetic Lethality Player With 3 Big Pharma Partners

Sep 07

Repare Therapeutics GAAP EPS of -$0.91 misses by $0.06, revenue of $0.67M

Aug 04

Repare Therapeutics: Interesting Gene Editing Company, But Miles To Go

Jun 27

Companies Like Repare Therapeutics (NASDAQ:RPTX) Are In A Position To Invest In Growth

Jun 24
Companies Like Repare Therapeutics (NASDAQ:RPTX) Are In A Position To Invest In Growth

Repare Therapeutics (NASDAQ:RPTX) Is In A Good Position To Deliver On Growth Plans

Mar 02
Repare Therapeutics (NASDAQ:RPTX) Is In A Good Position To Deliver On Growth Plans

We're Not Worried About Repare Therapeutics' (NASDAQ:RPTX) Cash Burn

Oct 14
We're Not Worried About Repare Therapeutics' (NASDAQ:RPTX) Cash Burn

We Think Repare Therapeutics (NASDAQ:RPTX) Can Easily Afford To Drive Business Growth

Apr 16
We Think Repare Therapeutics (NASDAQ:RPTX) Can Easily Afford To Drive Business Growth

Have Repare Therapeutics Inc. (NASDAQ:RPTX) Insiders Been Selling Their Stock?

Mar 12
Have Repare Therapeutics Inc. (NASDAQ:RPTX) Insiders Been Selling Their Stock?

Are Institutions Heavily Invested In Repare Therapeutics Inc.'s (NASDAQ:RPTX) Shares?

Feb 08
Are Institutions Heavily Invested In Repare Therapeutics Inc.'s (NASDAQ:RPTX) Shares?

Repare Therapeutics: CRISPR-Enabled Technology Might Unlock New Therapies

Dec 28

Trade Alert: The Executive VP & Head of Business & Corporate Development Of Repare Therapeutics Inc. (NASDAQ:RPTX), Kim Seth, Has Sold Some Shares Recently

Dec 21
Trade Alert: The Executive VP & Head of Business & Corporate Development Of Repare Therapeutics Inc. (NASDAQ:RPTX), Kim Seth, Has Sold Some Shares Recently

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: RPTX 'nin kısa vadeli varlıkları ( $228.5M ) kısa vadeli yükümlülüklerini ( $31.4M ) aşıyor.

Uzun Vadeli Yükümlülükler: RPTX şirketinin kısa vadeli varlıkları ( $228.5M ) uzun vadeli yükümlülüklerini ( $218.0K ) aşmaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: RPTX borçsuzdur.

Borcun Azaltılması: RPTX şirketinin 5 yıl önce borç/öz sermaye oranı 3.6% iken borcu yok.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: RPTX şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: RPTX serbest nakit akışı her yıl % 30.2 1.7 yıl yetecek nakit akışına sahip olacaktır.


Sağlıklı şirketleri keşfedin